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ABSTRACT
Background: Nausea and vomiting are common during the first half of pregnancy and usually
require only supportive measures. When symptoms are progressive and weight loss occurs, treatable
causes should be sought by means of upper gastrointestinal endoscopy. We report a case of an
immunocompetent gravida with invasive Candida albicans esophagitis.
Case: The immunocompetent primigravida developed progressive nausea, vomiting, epigastric
pain, and a 4.1 kg weight loss during the second trimester ofpregnancy. Treatment with metoclopra-
mide and cimetidine for presumed gastroesophageal refluxwas not effective. The patient had normal
T-cell CD4 and CD8 subsets and was human immunodeficiency virus (HIV) antibody negative.
Upper gastrointestinal endoscopy revealed C. albicans esophagitis which was treated with oral
nystatin. The esophagitis had resolved completely when reassessed postpartum. The use of hista-
mine2 blockers is associated with an increased risk for fungal esophagitis and may have been a
contributing cause in this case.
Conclusion: Pregnant patients with persistent nausea, vomiting, and weight loss should be evalu-
ated by endoscopy for fungal esophagitis. (C) 1993 Wiley-Liss, Inc.
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e report a case of Candida albicans esophagi-
tis in an immunocompetent gravida. We are
unaware of other reports of this infection compli-
cating pregnancy. We suggest that Canadida esoph-
agitis be included in the differential diagnosis of
refractory nausea, vomiting, and weight loss dur-
ing pregnancy.
CASE REPORT
A 37-year-old primigravida woman with a history
of leiomyomata presented for prenatal care at 8
weeks gestation with a uterus that was 20 weeks
size. At the age of 31 years, she had a positive
tuberculin skin test and a normal chest radiograph.
She refused isoniazid prophylaxis.
Physical examination at that time showed a
healthy, thin, black woman with a weight of 58.6
kg and a height of 167.5 cm. Pelvic ultrasonogra-
phy showed a single, viable, 9.5-week fetus in a
gestational sac near the cervix and a large fundal
leiomyoma with dimensions of 17 10 13.5
cm. All routine prenatal laboratory values were
normal. The patient declined human immunodefi-
ciency virus (HIV) antibody screening. An amnio-
centesis done at 15 weeks showed a normal karyo-
type, 46 XX, and a normal alpha feto-protein.
In the second trimester, she developed increas-
ing uterine pain, tenderness, and loss of appetite.
By 17 weeks gestation, her weight had decreased
1.8 kg to 56.8 kg.
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Fig. I. Histologic section of esophagus demonstrating invasive Candida infection. Acute inflamma-
tion and necrotic material are present in the lamina propria. Hematoxylin and eosin stain. 40.
Despite enteral supplementation, her weight de-
creased to 54.5 kg by 22 weeks gestation. She had
nausea, vomiting, and a sensation of obstruction in
her throat, but denied odynophagia. The uterus
was markedly tender and was 30 cm at 22 weeks
gestation. Degeneration of the leiomyomata was
diagnosed.
Hemoglobin was 10.7 g/dl, white blood cell
(WBC) count 8,800/mm
3 with a normal differen-
tial, platelets 613,000/mm3, total protein 5.6 g/dl,
and albumin 2.6 g/dl. All blood chemistries and
liver function tests were normal. Ultrasound
showed no hepatobiliary abnormalities and con-
firmed appropriate fetal growth.
Peripheral hyperalimentation was administered.
Gastroesophageal reflux was diagnosed and cimeti-
dine, 400 mg b.i.d., and metoclopramide, 10 mg
30-45 min before meals and at bedtime, were pre-
scribed. Her symptoms resolved temporarily; she
gained 2 kg. She refused further parenteral nutrition.
At 27 weeks gestation, nausea, vomiting, and
weight loss recurred. She had no oral thrush or
vaginal candidiasis. She denied having odynopha-
gia, retrosternal pain, hematemesis, or fever. The
uterine fundal height had increased to 3 8 cm. The
1-hr post-50 g glucola blood glucose was 151 mg/
dl. A 3-hr glucose tolerance test met criteria for the
diagnosis of gestational diabetes (fasting 77 mg/dl,
1-hr 194, 2-hr 167, and 3-hr 90). In order to
provide adequate calories, we placed no restrictions
and continued the Ensure (Ross Laboratories, Co-
lumbus, .OH). Subsequent fasting and postpran-
dial serum glucose concentrations remained nor-
mal. A 10 French-feeding tube was inserted for
enteral hyperalimentation. The tube became kinked
and stopped functioning after week. The patient
refused reinsertion of the tube until 32 weeks gesta-
tion. Upper gastrointestinal endoscopy (for place-
ment of a second feeding tube) revealed the classic
patchy white exudates of Candida esophagitis. No
feeding tube was placed. Fungal culture and histo-
logic section confirmed invasive C. albicans infec-
tion (Figs. 1, 2). Treatment was initiated with
nystatin suspension, 500,000 units swish and swal-
low q.i.d. Metoclopramide and cimetidine were
discontinued.
150 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYCANDIDA ESOPHAGITIS IN PREGNANCY GREENSPOON AND KIVNICK
Fig. 2. High-power view of Figure I. Histologic section of esophagus demonstrating invasive Can-
dida infection. Pseudohyphae are present within necrotic debris. Silver methenamine stain. 450.
The patient’s and her spouse’s serum HIV anti-
body enzyme-linked immunosorbent assay
(ELISA) tests were negative. The complete blood
count (CBC), T-cell panel, and serum protein elec-
trophoresis were normal. The WBC count was
10,600/mm3; lymphocytes were 18% of total (nor-
mal 15-40%); T-helper cells (CD4) were 48%
(normal 32-56%); and T-suppressor cells (CDS)
were 24% (normal 17-40%). Skin testing for
mumps showed 30 15 mm of erythema at 48 hr
after injection; coccidioidin caused no reaction.
Chest radiograph was normal. During the course
of antifungal therapy, the patient’s dysphagia de-
creased, but her oral intake remained poor and
abdominal pain increased. She remained euglyce-
mic. After fetal maturity was confirmed, a cesarean
delivery was performed at 36.5 weeks for breech
presentation and increasing abdominal pain.
The female infant weighed 2,848 g and had
Apgar scores of 9 and 9 at and 5 min, respec-
tively. There was a single fundal leiomyoma which
extended to the left hemidiaphragm. There was no
evidence of Candida esophagitis when upper gas-
trointestinal endoscopy was performed 3 days post-
partum.
Five months postpartum, a myomectomy was
performed. The leiomyoma weighed 852 g and
measured 15 15 x 7 cm. Pathologic examina-
tion revealed a hyalinized and infarcted leiomy-
oma. A preoperative HIV antibody test remained
negative.
DISCUSSION
We were unable to find other reports of Candida
esophagitis during pregnancy in immunocompe-
tent or immunocompromised patients. This diag-
nosis should be considered in patients with refrac-
tory nausea, vomiting, and weight loss during
pregnancy. This patient did not have the common
symptom of odynophagia or the presence of oral
thrush. The nystatin therapy improved the dys-
phagia, and a repeat endoscopic examination con-
firmed resolution of the esophagitis. The patient’s
dysphagia and the histologically proven Candida
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esophagitis cannot be attributed to the mass effect of
the gravid uterus and leiomyoma, although these
may have caused some of her epigastric discomfort.
Histamine2 blockers are widely used and are
usually well tolerated.
2 A significant association
exists between treatment with histamine2 blockers
and the presence of fungal esophagitis.
3 The prev-
alence of fungal esophageal infection was 12 of 72
(16.7%) among patients exposed to histamine2
blockers, whereas only 3.5% of patients unexposed
to the drug had fungal esophageal infection. The
association is somewhat unexpected because cimeti-
dine has been shown to enhance cell-mediated im-
munity in humans. Cimetidine augmented delayed
hypersensitivity responses to skin tests including
the Candida antigen in humans with duodenal-ul-
cer disease.
4 In 4 adult patients with chronic muco-
cutaneous candidiasis, cimetidine stimulated the im-
mune response to Candida antigen and the pro-
duction of leukocyte migration inhibitory factor,
although lymphocyte transformation was not af-
fected, s Cimetidine and ranitidine are FDA cate-
gory B drugs; their use during pregnancy should
be limited to instances in which the benefit justifies
the risk.
Type I diabetes mellitus has been associated with
Candida esophagitis. Although this patient met cri-
teria for gestational diabetes mellitus, because she
remained euglycemic, we do not think that her
glucose intolerance was severe enough to be a cause
for the fungal esophagitis. Perhaps the combina-
tion of pregnancy, diabetes mellitus, and treatment
with a histamine2 blocker may increase the risk for
Candida esophagitis.
Immunocompetent pregnant patients who have
not responded to routine therapy (or gastroesoph-
ageal reflux should undergo upper gastrointestinal
endoscopy to diagnose Candida esophagitis. If they
have been treated with histamine2 blockers, they are
at increased risk for esophageal fungal infection.
In immunocompromised pregnant patients, up-
per gastrointestinal endoscopy is particularly im-
portant to identify opportunistic esophageal infec-
tions. As HIV infection becomes more common in
obstetrical patients, Candida esophagitis and other
opportunistic infections will be encountered more
frequently. At this time, Candida esophagitis is the
acquired immunodeficiency syndrome (AIDS)-in-
dicator disease for 15% of HIV-infected adoles-
cents and adults.
Although this patient responded to oral nystatin
therapy, immunocompromised patients frequently
need prolonged systemic therapy with fluconazole,
ketoconazole, or amphotericin B.
6 The safety of
these systemic drugs during pregnancy has not been
established.
ACKNOWLeDGmeNTS
We thank Samuel H. Pepkowitz, M.D., for assis-
tance in preparing the photomicrographs.
REFERENCES
1. Haulk AA, Sugar AM: Candida esophagitis. In Stoller-
manGH (ed): Advances in Internal Medicine. Vol. 36. St.
Louis: Mosby Year Book, pp 307-318, 1991.
2. Lispy RJ, Fennerty B, Fagan TC: Clinical review of hista-
mine receptor antagonists. Arch Intern Med 150:745-
751, 1990.
3. Vermeersch B, Rysselaere M, Dekeyser K, Rasquin K,
De Vos M, Elewaut A, Barbier F: Fungal colonization
of the esophagus. Am J Gastroenterol 84:1079-1083,
1989.
4. Avella J, Madsen JE, Binder HJ, Askenase PW: Effect of
histamine I-I2-receptor antagonists on delayed hypersensi-
tivity. Lancet 1(8065):624-626, 1978.
5. Jorizzo JL, Sams WM Jr, Jegasothy BV, Olansky AJ:
Cimetidine as an immunomodulator: Chronic mucocutane-
ous candidiasis as a model. Ann Intern Med 92:192-195,
1980.
6. Terrell CL, Hughes CE: Antifungal agents used for
deep-seated mycotic infections. Mayo Clin Proc 67:69-91,
I992.
152 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY